A good provider will: Review your weight loss history Monitor labs and side effects
Some individuals also report experiencing relief from seasonal allergies, sinusitis, and upper respiratory tract infections
Its worth noting the first GLP-1 receptor agonist approved for the treatment of type 2 diabetes was Byetta (exenatide), which received approval, over 20 years ago, in 2005
In addition, GLP-1 RAs reduce blood pressure during chronic treatment, increase pulse rate, and reduce postprandial triglyceride concentrations
Scores were as follows: 1: substantially deteriorated, 2: mildly deteriorated, 3: no effect, 4: mildly improved, and 5: substantially improved
Key highlights Although semaglutide is an effective medication, some patients consider its alternatives due to cost and insurance issues, persistent shortages, intolerable side effects, insufficient results, certain health conditions, or a preference for pills